Get started
Author

Prashant A. Patil

Observed name: Prashant Patil
Observed institution: Megafine Pharma (India)
ORCID: 0009-0001-2941-1941
Observed ORCID: 0009-0001-2941-1941
OpenAlex ID: A5104542762
Identification, characterization, and control of stability-related phthalamic acid impurity in a rivaroxaban amino intermediate
2026 · Prashant A. Patil, Dattatray A. Chadar, et al. · Monatshefte für Chemie - Chemical Monthly
A multi-responsive chemosensor for selective recognition of Pb2+, Cr3+ and Fe3+ in aqueous media with cellular imaging applications
2026 · Jitendra Nandre, Darshana Patil, et al. · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
PDF
Identification of Selexipag amorphous Polymorphs and Development of an Efficient Synthetic Process for Their Preparation.
2026 · Pritesh Kardile, Dattatray Chadar, et al. · Research Digest on Engineering Management and Social Innovations
PDF
An improved and industrially viable process for the synthesis of edoxaban with efficient control of process impurities
2026 · Pritesh B. Kardile, Gorakshanath B. Shinde, et al. · Monatshefte für Chemie - Chemical Monthly
Improved and Scalable Single-Pot Process for Selexipag and Its Key Intermediate
2026 · Pritesh B. Kardile, Gorakshanath B. Shinde, et al. · Organic Preparations and Procedures International
A Novel Synthetic Route of (Z)-Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate: A Key Intermediate of Apixaban
2025 · Leena N. Patil, Mubarak Ali R. Sayyed, et al. · Asian Journal of Chemistry
PDF
Synthesis and Characterization of Chiral Impurities of Edoxaban Tosylate Monohydrate, Used As an Anticoagulant Drug
2025 · Pritesh Kardile, Dattatray Chadar, et al. · International Research Journal on Advanced Engineering and Management (IRJAEM)
Synthesis and Characterization of Chiral Impurities of Mirabegron, Used as an Overactive Bladder Drug
2024 · Prashant A. Patil, Sneha N. Tambat, et al. · International Research Journal on Advanced Engineering and Management (IRJAEM)
Synthesis and Characterization of Chiral Impurities of Rivaroxaban, Used as an Anticoagulant Drug
2024 · Prashant A. Patil, Sneha N. Tambat, et al. · International Research Journal on Advanced Engineering and Management (IRJAEM)
PDF
Works count: 10
Citation count:
H-index:
I10-index:
Year
Topic
Type